Journey Medical NASDAQ DERM Reports 21 Revenue Growth in Q1 2026 Remains Unprofitable VEON Ltd VEON Q1 2026 Earnings Beat Revenue NA EPS 139 Stock Market Investors Get Warning Signs on Trump Economy Historical Patterns Point to Potential Domino Effect OilDriven Inflation Surge Raises Odds Fed Keeps Rates Elevated X4 Pharmaceuticals XFOR Q1 2026 Earnings Why the Beat Matters Maersk Profit Falls Sharply Firm Maintains 2026 Outlook Amid Hormuz Uncertainty Citadel Issues Relocation Ultimatum to Hong KongBased Quantitative Researchers